We expect Perrigo Company plc (PRGO) to surpass expectations when it reports first-quarter 2025 earnings on May 7, before the opening bell. The company’s earnings beat estimates by 1.09% in the last reported quarter.The Zacks Consensus Estimate for sales and earnings is pegged at $1.08 billion and 53 cents per share, respectively. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)Factors Shaping PRGO’s Upcoming ResultsPerrigo reports its results under two segments: Consumer Self Care ...

Group 1 - The majority of small and mid-cap software companies have reported positive earnings surprises during the Q1 earnings season, which has helped mitigate volatility in the market [1] - The volatility in the market began with the onset of Trump's new policies, impacting the technology sector [1] - Gary Alexander has extensive experience in covering technology companies and has been a contributor to Seeking Alpha since 2017, providing insights into industry trends [1]

WESCO International (WCC) reported first-quarter 2025 adjusted earnings of $2.21 per share, down 3.9% year over year. The bottom line missed the Zacks Consensus Estimate by 0.90%.Net sales were $5.34 billion, down 0.1% year over year due to continued weakness in the utility business. However, the figure beat the Zacks Consensus Estimate by 2.10%. Organic sales increased 5.6% year over year.Following the release, WCC shares rose 0.97% in the pre-market trading as investors responded positively to robust orga ...

Core Viewpoint - Opus Genetics, Inc. is anticipated to report a year-over-year decline in earnings despite an increase in revenues for the quarter ending March 2025, with the consensus outlook indicating a significant impact on the stock price based on actual results compared to estimates [1][3]. Financial Performance Expectations - The company is expected to post a quarterly loss of $0.34 per share, reflecting a year-over-year change of -17.2% [3]. - Revenues are projected to be $2.8 million, which represents a 63.7% increase from the same quarter last year [3]. Estimate Revisions and Predictions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analyst expectations [4]. - The Most Accurate Estimate aligns with the Zacks Consensus Estimate, resulting in an Earnings ESP of 0%, suggesting no recent differing analyst views [10]. Earnings Surprise History - In the last reported quarter, the company was expected to post a loss of $0.34 per share but instead reported a loss of $1.27, resulting in a surprise of -273.53% [12]. - Over the past four quarters, Opus Genetics has only beaten consensus EPS estimates once [13]. Industry Comparison - Cue Biopharma, another player in the Zacks Medical - Biomedical and Genetics industry, is expected to report a loss of $0.14 per share for the same quarter, indicating a year-over-year change of +44% [17]. - Cue Biopharma's revenues are expected to be $2 million, up 16.3% from the previous year, with an unchanged consensus EPS estimate over the last 30 days [17][18].

Company Overview - Veren (VRN) is expected to report a year-over-year increase in earnings of +31.8% to $0.29 per share, despite a revenue decline of 12.4% to $719.9 million for the quarter ended March 2025 [3][12] - The stock's price movement will largely depend on how actual results compare to consensus estimates, with a potential for higher stock prices if results exceed expectations [1][2] Earnings Estimates and Revisions - The consensus EPS estimate for Veren has been revised 25% higher in the last 30 days, indicating a bullish sentiment among analysts [4] - The Most Accurate Estimate for Veren is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +13.79%, suggesting a strong likelihood of beating the consensus EPS estimate [10][11] Earnings Surprise History - In the last reported quarter, Veren exceeded expectations by delivering earnings of $0.29 per share against an expected $0.24, resulting in a surprise of +20.83% [12] - Over the last four quarters, Veren has beaten consensus EPS estimates only once, indicating a mixed performance history [13] Industry Context - In the Zacks Oil and Gas - Integrated - Canadian industry, Cenovus Energy (CVE) is expected to report earnings of $0.29 per share, reflecting a year-over-year decline of -37%, with revenues projected at $9.55 billion, down 3.9% [17] - Cenovus has seen a 1.6% downward revision in its consensus EPS estimate over the last 30 days, and its Earnings ESP is currently at 0.00%, making it difficult to predict a beat against consensus estimates [18]

Core Viewpoint - The market anticipates Costamare (CMRE) will report a year-over-year decline in earnings due to lower revenues for the quarter ended March 2025, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - Costamare is expected to post quarterly earnings of $0.52 per share, reflecting a year-over-year decrease of 17.5% [3]. - Revenues are projected to be $412.67 million, down 13.2% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 17% higher in the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for Costamare is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +6.80% [10][11]. Earnings Surprise Prediction - A positive Earnings ESP reading suggests a potential earnings beat, especially when combined with a strong Zacks Rank [8]. - However, Costamare currently holds a Zacks Rank of 4, complicating the prediction of an earnings beat despite the positive Earnings ESP [11]. Historical Performance - In the last reported quarter, Costamare exceeded the expected earnings of $0.66 per share by delivering $0.69, resulting in a surprise of +4.55% [12]. - The company has beaten consensus EPS estimates in each of the last four quarters [13]. Industry Context - In the Zacks Transportation - Shipping industry, Ardmore Shipping (ASC) is expected to report earnings of $0.15 per share, indicating a year-over-year decline of 83.7% [17]. - Ardmore Shipping's consensus EPS estimate has been revised 37.8% lower in the last 30 days, leading to an Earnings ESP of -10.35% [18].

Xenia Hotels & Resorts (XHR) reported $288.93 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 8%. EPS of $0.51 for the same period compares to $0.08 a year ago.The reported revenue represents a surprise of +5.66% over the Zacks Consensus Estimate of $273.46 million. With the consensus EPS estimate being $0.42, the EPS surprise was +21.43%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to ...

Core Viewpoint - The energy sector is facing challenges due to macroeconomic uncertainty and commodity price volatility, but some companies are positioned to potentially exceed earnings expectations, which could positively impact their stock prices in the near term [1]. Sector Snapshot - Oil prices have decreased in Q1 2025, with West Texas Intermediate crude averaging $71.84 per barrel, down from $77.56 in Q1 2024, attributed to soft global demand, rising inventories, and increased non-OPEC+ production [2]. - U.S. natural gas prices have rebounded sharply, averaging $4.15 per MMBtu compared to $2.13 a year ago, driven by colder weather and growing LNG exports [2]. Earnings Expectations - S&P 500 energy firms are projected to report a 12.9% year-over-year decline in earnings and a 0.3% dip in revenues, indicating ongoing pressure on profit margins [3][5]. - This decline is an improvement from the 22.4% earnings drop in Q4 2024, but still reflects significant challenges for oil-centric companies [3][6]. Company Performance Insights - Some energy companies are expected to perform better due to effective cost management, operational efficiency, and a focus on natural gas, which may lead to earnings surprises [4][7]. - Energy Transfer (ET) has an Earnings ESP of +9.23% and a Zacks Rank 3, with earnings scheduled for release on May 6 [11][12]. - MPLX LP also has a +9.23% Earnings ESP and a Zacks Rank 3, with earnings set to be released on May 6 [12]. - Pembina Pipeline (PBA) has an Earnings ESP of +2.93% and a Zacks Rank 3, with earnings scheduled for May 8 [13]. - ConocoPhillips (COP) has an Earnings ESP of +2.76% and a Zacks Rank 3, with earnings also scheduled for May 8 [14].

Core Viewpoint - DuPont de Nemours, Inc. reported a loss from continuing operations of $548 million or $1.33 per share for Q1 2025, contrasting with a profit of $183 million or 41 cents per share in the same quarter last year. However, adjusted earnings were $1.03 per share, exceeding the Zacks Consensus Estimate of 95 cents. Net sales reached $3,066 million, up 4.6% year over year, surpassing the Zacks Consensus Estimate of $3,040 million [1][2]. Segment Highlights - The ElectronicsCo segment achieved net sales of $1,118 million, reflecting a year-over-year increase of 13.6%. Organic sales rose by 14%, driven by a 16% increase in volume, despite a 2% decline in price [2]. - The IndustrialsCo segment recorded net sales of $1,948 million, remaining flat year over year. This was due to 2% organic growth being offset by a 1% currency headwind and a 1% adverse portfolio impact [3]. Financials - At the end of the quarter, DuPont had cash and cash equivalents of $1,762 million, a decrease of approximately 4.8% sequentially. Long-term debt stood at $5,325 million, unchanged sequentially. The company generated operating cash flow from continuing operations of $382 million during Q1 [4]. Outlook - For Q2 2025, DuPont projects net sales of approximately $3.2 billion, operating EBITDA of around $815 million, and adjusted earnings per share of about $1.05. This outlook indicates a seasonal sequential increase in sales, although the rise is more subdued than previously anticipated due to timing shifts in the Semiconductor Technologies business [5][6]. Price Performance - Over the past year, DuPont's shares have declined by 15.1%, compared to a 25.4% decline in the industry [7]. Zacks Rank & Key Picks - DuPont currently holds a Zacks Rank 3 (Hold). Other better-ranked stocks in the basic materials sector include Hawkins, Inc. (Zacks Rank 1), SSR Mining Inc. (Zacks Rank 2), and Intrepid Potash, Inc. (Zacks Rank 2) [8].

Group 1 - Workiva reported $206.28 million in revenue for the quarter ended March 2025, a year-over-year increase of 17.4% [1] - The EPS for the same period was $0.14, down from $0.22 a year ago, with a surprise of +100.00% compared to the consensus estimate of $0.07 [1] - The reported revenue exceeded the Zacks Consensus Estimate of $203.87 million by +1.18% [1] Group 2 - Subscription and support revenue was $185.51 million, surpassing the average estimate of $184.23 million, reflecting a year-over-year change of +19.7% [4] - Professional services revenue reached $20.77 million, exceeding the average estimate of $19.60 million, with a year-over-year change of +0.4% [4] - Gross profit for professional services (non-GAAP) was $7.48 million, above the average estimate of $6.69 million, while subscription and support gross profit (non-GAAP) was $154.79 million, slightly above the average estimate of $153.98 million [4] Group 3 - Workiva's shares have returned -2.4% over the past month, compared to the Zacks S&P 500 composite's -0.7% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]